دورية أكاديمية

LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial

التفاصيل البيبلوغرافية
العنوان: LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
المؤلفون: Bruix, J., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Yokosuka, O., Rosmorduc, O., Breder, V., Gerolami, R., Masi, G., Ross Paul, J., Qin, S., Song, T., Bronowicki, J.-P., Ollivier-Hourmand, I., Kudo, M., LeBerre, M.-A., Baumhauer, A., Meinhardt, G., Han, G.
المصدر: In Annals of Oncology June 2016 27 Supplement 2:ii140-ii140
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw237.03